BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19173001)

  • 21. Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate.
    Rossetti S; Ren M; Visconti N; Corlazzoli F; Gagliostro V; Somenzi G; Yao J; Sun Y; Sacchi N
    Oncotarget; 2016 Dec; 7(52):87064-87080. PubMed ID: 27894085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAC1 negatively regulates RARα activity through cooperation with HDAC.
    Moon M; Um SJ; Kim EJ
    Biochem Biophys Res Commun; 2012 Oct; 427(1):41-6. PubMed ID: 22982681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid receptor-alpha is stabilized in a repressive state by its C-terminal, isotype-specific F domain.
    Farboud B; Privalsky ML
    Mol Endocrinol; 2004 Dec; 18(12):2839-53. PubMed ID: 15331758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis reveals that all-trans-retinoic acid, 9-cis-retinoic acid, and antagonist interact with distinct binding determinants of RARalpha.
    Keidel S; Lamour FP; Apfel CM
    J Biol Chem; 1997 Jul; 272(29):18267-72. PubMed ID: 9218465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A; Buchholz DR; Obata K; Shi YB
    J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.
    Fazi F; Zardo G; Gelmetti V; Travaglini L; Ciolfi A; Di Croce L; Rosa A; Bozzoni I; Grignani F; Lo-Coco F; Pelicci PG; Nervi C
    Blood; 2007 May; 109(10):4432-40. PubMed ID: 17244680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms.
    Vreeland AC; Levi L; Zhang W; Berry DC; Noy N
    J Biol Chem; 2014 Dec; 289(49):34065-73. PubMed ID: 25320093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Ser(289) in RARgamma and its homologous amino acid residue of RARalpha and RARbeta in the binding of retinoic acid.
    Zhang ZP; Shukri M; Gambone CJ; Gabriel JL; Soprano KJ; Soprano DR
    Arch Biochem Biophys; 2000 Aug; 380(2):339-46. PubMed ID: 10933889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.
    Srinivas H; Juroske DM; Kalyankrishna S; Cody DD; Price RE; Xu XC; Narayanan R; Weigel NL; Kurie JM
    Mol Cell Biol; 2005 Feb; 25(3):1054-69. PubMed ID: 15657432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
    Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
    Lin F; Xiao D; Kolluri SK; Zhang X
    Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A regulatory circuit controlled by extranuclear and nuclear retinoic acid receptor α determines T cell activation and function.
    Larange A; Takazawa I; Kakugawa K; Thiault N; Ngoi S; Olive ME; Iwaya H; Seguin L; Vicente-Suarez I; Becart S; Verstichel G; Balancio A; Altman A; Chang JT; Taniuchi I; Lillemeier B; Kronenberg M; Myers SA; Cheroutre H
    Immunity; 2023 Sep; 56(9):2054-2069.e10. PubMed ID: 37597518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A RARE of hepatic Gck promoter interacts with RARα, HNF4α and COUP-TFII that affect retinoic acid- and insulin-induced Gck expression.
    Li R; Zhang R; Li Y; Zhu B; Chen W; Zhang Y; Chen G
    J Nutr Biochem; 2014 Sep; 25(9):964-76. PubMed ID: 24973045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postnatal Ablation of Synaptic Retinoic Acid Signaling Impairs Cortical Information Processing and Sensory Discrimination in Mice.
    Park E; Tjia M; Zuo Y; Chen L
    J Neurosci; 2018 Jun; 38(23):5277-5288. PubMed ID: 29760176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoic acid controls body axis extension by directly repressing Fgf8 transcription.
    Kumar S; Duester G
    Development; 2014 Aug; 141(15):2972-7. PubMed ID: 25053430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of tyrosine 277 in the ligand-binding and transactivating properties of retinoic acid receptor alpha.
    Mailfait S; Belaiche D; Kouach M; Dallery N; Chavatte P; Formstecher P; Sablonnière B
    Biochemistry; 2000 Mar; 39(9):2183-92. PubMed ID: 10694383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid-gated sequence-specific translational control by RARalpha.
    Poon MM; Chen L
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20303-8. PubMed ID: 19073915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription.
    Giannì M; Parrella E; Raska I; Gaillard E; Nigro EA; Gaudon C; Garattini E; Rochette-Egly C
    EMBO J; 2006 Feb; 25(4):739-51. PubMed ID: 16456540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.